In-depth studies have shown that TIMP1 accelerates cell proliferation by activating YAP/TAZ in cancer, suggesting that the TIMP1-YAP/TAZ axis may be a potential new drug target for treating cancer patients. The gene discussed is TIMP1; the disease is cancer.